newsfilter
← Latest News
Bloomberg·

Mallinckrodt to Buy Questcor in $5.6 Billion Drugs Deal

Mallinckrodt Plc agreed to buy Questcor Pharmaceuticals Inc. for $5.6 billion to add specialty drugs in the latest industry deal that moves a U.S. company to Ireland for a lower tax rate.